Axitinib (CAS 319460-85-0) Supplier Information and Product Details

Supply Ability: Ranges from 10kg/month to 200kg/month depending on the supplier

Minimum Order: Varies from 1g to 100kg depending on the supplier

Frequently Asked Questions about Axitinib

Q: What is Axitinib?

A: Axitinib is an oral inhibitor of VEGF, PDGF, and colony-stimulating factor 1 receptor tyrosine kinases. It is FDA-approved for treating advanced kidney cancer.

Q: What are some synonyms for Axitinib?

A: Some synonyms for Axitinib include: - N-methyl-2-[[3-[(E)-2-pyridin-2-ylvinyl]-1H-indazol-6-yl]sulfanyl]benzamide - AG-013736 - INLYTA (brand name)

Q: What is the biological activity of Axitinib?

A: Axitinib is an inhibitor of tyrosine kinases, specifically targeting VEGF, PDGF, and colony-stimulating factor 1 receptors. It is used in the treatment of advanced kidney cancer.